治疗患者的焦虑和抑郁症
Emanuele F Osimo1,2,3,4,5, Paul C Fletcher1,2,3, Thomas E Cope6,3,7,8
1Psychiatry, University of Cambridge, Cambridge, UK.
Practical neurology
|May 28, 2025
概括
神经科医生在治疗患者的抑郁症方面面临挑战,原因是时间和信心障碍. 常规的情绪评估和可访问的心理健康转诊对于管理相关的焦虑和抑郁症至关重要.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 心理健康 心理健康
背景情况:
- 患有的患者有显著增加的焦虑,抑郁和自杀风险.
- 目前的治疗往往忽视了心理健康,尽管其患病率和影响很高.
- 在诊所治疗抑郁症的障碍包括缺乏时间和临床医生的信心.
研究的目的:
- 强调将心理健康评估纳入常规护的重要性.
- 为神经病学家和护士提供治疗抑郁症的实用指导.
- 鼓励积极的心理健康管理与抗发作药物处方一起进行.
主要方法:
- 审查当前的临床实践和诊所的障碍.
- 讨论可用的心理健康资源和转诊途径.
- 提供实用建议,以启动关于心理健康的对话.
主要成果:
- 缺乏时间和信心是发现和治疗时抑郁症的主要障碍.
- 心理健康谈话应该像讨论中突然意外死亡 (SUDEP) 一样是常规的.
- 神经病学家可以开处 serotonin 再吸收抑制剂 (SRIs),并提供明确的转诊途径,以提供进一步的支持.
结论:
- 神经科医生需要信心和知识来解决患者的抑郁症.
- 提高心理福利服务的认识和利用,包括自我推,是必不可少的.
- 考虑心理健康影响,特别是使用诸如 levetiracetam 等药物,对于全面治疗至关重要.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.6K
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.5K
相关概念视频
Electroconvulsive Therapy
927
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
927
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Drug Therapy
246
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
246
Antiepileptic Drugs: Glutamate Antagonists
906
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
906
Antiepileptic Drugs: Potassium Channel Activators
637
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
637
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
